(OA03) A Phase II Study of Stereotactic Body Radiotherapy and Stereotactic Body Proton Therapy for High-Risk Medically Inoperable Early-Stage Non-Small Cell Lung Cancer

We sought to compare the toxicity and efficacy of stereotactic body radiotherapy (SBRT) versus stereotactic body proton therapy (SBPT) for high-risk medically inoperable early-stage non-small cell lung cancer (NSCLC).

Source: International Journal of Radiation Oncology * Biology * Physics - May 3, 2018 Category: Radiology Authors: Joe Y. Chang, Chonnipa Nantavithya, Daniel R. Gomez, Ritsuko Komaki, Zhongxing Liao, Xiong Wei, Steven H. Lin, Melenda Jeter, Quynh-Nhu Nguyen, Heng Li, Xiaodong Zhang, Falk Poenisch, X Ronald Zhu, Peter A. Balter, Radhe Mohan, Lei Feng, Noah C. Choi, Joe Tags: Oral Abstract Source Type: research